Mirum Pharmaceuticals, Inc. (MIRM)
105.16
-0.33
(-0.31%)
USD |
NASDAQ |
Feb 20, 16:00
106.47
+1.31
(+1.25%)
After-Hours: 20:00
Mirum Pharmaceuticals SG&A Expense (Quarterly) : 61.91M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Insmed, Inc. | 0.00 |
| Pfizer Inc. | 4.162B |
| BridgeBio Pharma, Inc. | 137.62M |
| XOMA Royalty Corp. | 9.734M |
| CorMedix, Inc. | 36.64M |